Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. is a leading clinical-stage biotechnology company focused on designing and delivering innovative, best-in-class monoclonal antibodies. Dianthus Therapeutics is committed to unlocking the full potential of complement therapeutics through superior selectivity and potency, aiming to transform the treatment landscape for severe autoimmune and inflammatory diseases.

Operating from its primary location at 7 Times Square, Floor 43, New York City, New York, and with an additional site at 203 Crescent St, Building 4, Suite 205, Waltham, Massachusetts, Dianthus Therapeutics is driven by an experienced team of biotech and pharmaceutical executives. The company is dedicated to advancing next-generation antibody complement therapeutics, ensuring the development of transformative medicines that significantly improve patient outcomes.

Dianthus Therapeutics, Inc. is dedicated to making a meaningful impact on healthcare through its pioneering research and development efforts. We invite the manager of Dianthus Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative work and attract new opportunities.